A recent analysis of FitBit data suggests there is no one “normal” resting heart rate for humans, with users’ average HR coming in at between 40 and 109 beats per minute, Discover Magazine reported.

The study, published in the journal…

Medtronic has received CE mark approval in the European Union for its Cobalt and Crome implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy-defibrillators (CRT-Ds).

The company, which is based in Dublin,…

A panel of experts from the Clinical Genome Resource (ClinGen) are publicly disputing nine of 17 genes once thought to be linked to long QT syndrome.

In their report, published in …

Emergency phone operators in Victoria, Australia, may soon have access to AI that could alert them to callers in cardiac arrest, ZDNet reports.

According to ZDNet, the Victorian government announced Feb. 2 that it would be funneling $1.36…

The FDA has approved a Medtronic-run trial, PULSED AF, to evaluate the safety and efficacy of new tech that uses pulsed electric fields to treat AFib.

The study will be an investigational device exemption (IDE) trial, according to…

Burnout may increase a person’s risk of developing atrial fibrillation by as much as 20%, researchers reported this month in the European Journal of Preventive Cardiology.

Parveen K. Garg, MD, of the University of Southern…

Medtronic announced Jan. 21 it had received FDA approval for its Micra AV device—the world’s smallest pacemaker with atrioventricular (AV) synchrony.

Micra AV is identical in size and shape to Medtronic’s original Micra Transcatheter…

A medical technique that involves safely hyperventilating conscious, unmedicated patients could facilitate the use of radiotherapy for cardiac ablation, according to research published in…

The Heart Rhythm Society (HRS) and Consumer Technology Association (CTA) will debut new consumer guidelines this week focused on wearables that detect and monitor cardiovascular metrics.

Digital health devices, including smartwatches,…

A study published in…

Researchers at the University of Houston are pioneering a unique method for developing biological pacemakers: converting stem cells found in fat to biologic pacemaker cells.

Pharmacologist and UH associate professor…

New research out of Spain suggests we’re one step closer to personalized medicine for patients with atrial fibrillation.

The effort, led by David Filgueiras, MD, PhD, and colleagues at the Centro Nacional de…

Atrial fibrillation patients who are obese are less likely to respond to sodium channel blockers than their normal-weight peers, according to a new study.

Obesity is a known risk factor for AFib, senior author Dawood Darbar,…

Patients with atrial fibrillation may be more likely to stick to a regimen of oral anticoagulation if they’re first prescribed OACs in the emergency department, according to a study published Dec. 9 in the…

Brushing teeth three or more times a day could dramatically lower a person’s risk for CVDs like heart failure and atrial fibrillation, according to preliminary research out of Ewha Womans University in Seoul, South Korea.

People trained to perform CPR with a virtual reality tool were able to achieve comparable chest compression rates as those trained face-to-face in a recent randomized study—but the VR approach still has a long way to go.

A senior at a Utah high school received a scholarship this month based on her idea for an automated CPR assistance device.

Kennedy Hall, of Cedar Valley High School in Eagle Mountain, Utah, came up with the idea for…

A novel pacemaker designed to mimic a patient’s organic breath increased blood flow to the heart in a study of individuals with heart failure, according to research published in the journal…

Research that will be presented at the American Heart Association’s Resuscitation Science Symposium in Philadelphia this month suggests the National Institutes of Health (NIH) invests far less money in cardiac arrest research than in…

Taller people might be at an increased risk for atrial fibrillation, according to research set for presentation at the American Heart Association’s Scientific Sessions on Nov. 16.

Lead author Michael Levin, MD, and…

The net clinical benefit (NCB) of anticoagulants like warfarin and apixaban slows over time in patients with atrial fibrillation, according to a Circulation:…